Zymeworks Announces First Patient Dosed In Phase 1 Clinical Trial Evaluating ZW171 In Advanced Mesothelin-Expressing Cancers

(MENAFN - GlobeNewsWire - Nasdaq) Global Phase 1 clinical trial will evaluate the safety and tolerability of ZW171 in treatment of ovarian cancer, non-small cell lung cancer (NSCLC), and other ...

By: menafn